Home
>
US Stocks
>
Nevro Corp
Nevro Corp
NVRO

Nevro Corp

$117.462.45%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
113.86
Today Low/High
113.86 / 118.1
52 Week Low/High
$99.54 / $188.14
P/E ratio
-56.3705
Market Cap
$3.85B

Company Details

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
Organisation
Nevro Corp
Headquaters
Redwood City, California, US
Employees
843
Industry
Health Technology
CEO
D.Keith Grossman

Discover more

Frequently Asked Questions

What is Nevro Corp share price today

Can Indians buy Nevro Corp shares?

How can I buy Nevro Corp shares from India?

Can Fractional shares of Nevro Corp be purchased?

What are the documents required to start investing in Nevro Corp stocks?

We are a SEBI registered investement advisor